Medical Innovation

Search documents
Stryker to announce financial results for its second quarter of fiscal year 2025
GlobeNewswire News Room· 2025-07-01 12:00
Portage, Michigan, July 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its second quarter of fiscal year 2025 on Thursday, July 31, 2025. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s second quarter that ended June 30, 2025. Stryker will host a webcast at 4:30 p.m. ET on Thursday, July 31, 2025, to discuss its ...
Karolinska Development divests shares in portfolio company OssDsign
Globenewswire· 2025-06-30 08:42
Core Viewpoint - Karolinska Development AB has divested its remaining shares in OssDsign, resulting in a capital injection of approximately SEK 34.5 million, which strengthens the company's liquidity and allows for prioritization of other investments with greater value creation potential [1][2]. Company Overview - Karolinska Development AB is a Nordic life sciences investment company focused on identifying breakthrough medical innovations in the Nordic region, investing in the creation and growth of companies that advance these innovations into commercial products [4][5]. - The company has access to world-class medical innovations from the Karolinska Institutet and other leading universities and research institutes in the Nordic region, aiming to build companies around leading scientists supported by experienced management teams [5][6]. Investment Strategy - The divestment from OssDsign reflects a strategic decision to realize profits and enhance the financial position of Karolinska Development, enabling the company to invest in other holdings with higher potential returns [2][3]. - Following the divestment, Karolinska Development has no direct ownership in OssDsign but retains indirect ownership through the KCIF Co-Investment Fund [3]. Portfolio and Management - Karolinska Development has a portfolio of eleven companies targeting innovative treatments for life-threatening or serious debilitating diseases, led by an entrepreneurial team of investment professionals with a proven track record [6].
Johnson & Johnson CEO: “We’re in the Golden Era of Medical Innovation”
Bloomberg Television· 2025-06-17 19:38
[Music] the uh center of the action of our research of development organization which is the lifeblood of a company like Johnson and Johnson. So here we have about 2500 scientists and researchers that are connected with the rest of our R&D organization. Duatau is chairman and CEO of Johnson and Johnson, one of the largest drug makers in the world.We met with him at his firm's research center to learn how a major pharmaceutical company develops cuttingedge drugs. It started with a smaller campus and graduall ...
Safe Group announces FDA 510(k) clearance for SpineUp's Frida solution
Globenewswire· 2025-06-10 16:04
Safe Group announces FDA 510(k) clearance for SpineUp's Frida solution Fleurieux-sur-l’Arbresle - France - June 5, 2025 at 6 p.m. Safe Group, a leading player in the field of medical devices for spine surgery, is pleased to announce that Frida, the innovative cervical plate developed by SpineUp, has received 510(k) clearance from the Food and Drug Administration (FDA). This clearance marks a crucial step in SpineUp's expansion into the North American market, and testifies to its ongoing commitment to provid ...
2025年服贸会健康卫生服务专题推介会召开
Huan Qiu Wang· 2025-06-08 13:38
来源:新华网 中国医院协会常务副会长毛群安对"首都国际医学大会"进行了重点推介。本次大会以"开放、合作、共 建、共享"为主题,设有主论坛及六场平行分论坛,涵盖医学创新、全民健康覆盖、临床研究、医防融 合等议题,推动"政策-技术-服务"全链条对话,促进中外卫生健康交流合作,促进跨界融合交流,共同 推动医学科技创新,鼓励和支持创新成果应用,让群众享受更加公平可及、全生命周期的健康服务。 本届服贸会继续围绕"全球服务、互惠共享"的永久主题,结合2025年服务贸易数字化和智能化发展新趋 势,设置年度主题"数智领航,服贸焕新"。继续设置以健康卫生服务为代表的9个专题,重点展示数字 技术、人工智能等新技术在服务贸易领域的应用,不断促进服务业扩大开放和服务贸易高质量发展。 中国医院 协会常务副会长毛群安发言。新华网 毕尚宏摄 活动现 场。新华网 毕尚宏摄 新华网北京6月8日电(毕尚宏)2025年中国国际服务贸易交易会(以下简称"服贸会")健康卫生服务专 题推介暨首都国际医学大会启动会6月8日在国家会议中心召开。 据介绍,2025年服贸会健康卫生服务专题将于9月10日至14日在首钢园举行,专题将在二号馆设置"智疗 云枢前瞻矩 ...
Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
Prnewswire· 2025-06-05 13:00
ALAMEDA, Calif., June 5, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby® XL System, the longest, largest and softest coil on the marketi. The Ruby XL System is designed to help physicians achieve more efficient embolization, potentially reducing radiation exposure, and optimizing outcomes — especially in large vessel and high-flow embolizationii. Penumbra Introduces the Ruby® XL System – the Longest, Largest, and Sof ...
Penumbra (PEN) 2025 Conference Transcript
2025-06-04 14:57
Penumbra (PEN) 2025 Conference June 04, 2025 09:55 AM ET Speaker0 Okay. So we're ready to kick off. This is the fireside chat with Penumbra. My name is Mike Sarcone. I'm one of the analysts on the US medical supplies and devices team. And with us from the company today, we have Adam El Seltzer. He's co founder, president, chairman, and CEO. We've also got Jason Mills, director of strategy. And Cecilia Furlong, who is a director of business Development, is also here with us. So team, thank you for joining us ...
Establishment Labs Holdings (ESTA) 2025 Conference Transcript
2025-06-04 12:35
Establishment Labs Holdings (ESTA) 2025 Conference June 04, 2025 07:35 AM ET Speaker0 Good morning, everybody. Thanks for joining us here for our first session in the med tech track. I'm Matt Taylor, the US medical supplies and devices analyst here at Jefferies. And I'm joined by the management team on my left here for Establishment Labs. So we have Pete Caldini, who's the CEO, and Raj Denhoy, the CFO. And we'll have about a half hour for moderated q and a. So I always like to start high level, especially f ...
J&J(JNJ) - 2025 FY - Earnings Call Transcript
2025-05-28 14:00
Johnson & Johnson (JNJ) FY 2025 Conference May 28, 2025 09:00 AM ET Speaker0 Alright. Thank you, everybody. Thanks, guys. I'm Lee Hambrite, US med tech analyst at Bernstein, and we are thrilled to host Johnson and Johnson. We have chairman and CEO, Joaquin Guato, and CFO, Joe Wall. Guys, for being here. Speaker1 Thank you. Thanks for having us. Speaker0 So we're scheduled for a fifty minute fireside chat. Just a reminder that investors can submit questions at any time through Pigeonhole, and we'll try to wo ...
姚高员主持召开全市生物医药产业生态圈高质量发展工作座谈会
Hang Zhou Ri Bao· 2025-05-16 03:14
姚高员强调,要围绕大平台、大产业,按照"一核引领、四园协同、全域成链"的产业发展空间格 局,提升产业集聚度、加速布局前沿赛道、培育标志性产品和领军企业,打造生物医药产业新增长极。 要围绕大攻关、大转化,加强源头创新能力、做优企业创新平台、加快创新成果转化、夯实高水平人才 支撑,加快开创性基础研究和应用性基础研究,以科技创新推动产业创新。要围绕大招引、大投资,紧 盯生物医药龙头企业招引和内生裂变项目培育,推动更多项目"落地生根""开花结果"。杭州将持续优化 营商环境,常态化倾听企业需求建议,谋划推进一批有针对性的"牵一发动全身"政策举措,全力构建良 好产业生态,全链条支持企业创新发展,以更加精准高效的服务助力企业深耕杭州、成长壮大。 姚高员指出,做大做强生物医药产业是因地制宜发展新质生产力的重要突破口之一。要紧紧围绕加 快打造生物医药创新高地和产业高地的目标任务,切实增强信心底气、坚持目标导向、聚焦重点问题, 清醒分析差距,努力做大做强做优生物医药产业集群,不断塑造发展新动能新优势。 5月15日,市长姚高员主持召开全市生物医药产业生态圈高质量发展工作座谈会。他强调,要认真 学习贯彻习近平总书记关于科技创新、产业 ...